These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 27129118)

  • 1. Safety, tolerability, pharmacokinetics, and pharmacodynamics of compound SFDAC by intranasal administration of multiple escalating dose in healthy male subjects.
    Thennati R; Khanna A; Khanna M; Sonaiya T; Mehta T; Mehta K; Shahi P; Patel J
    Clin Pharmacol Drug Dev; 2014 Nov; 3(6):428-38. PubMed ID: 27129118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of fluticasone propionate and mometasone furoate aqueous nasal sprays.
    Daley-Yates PT; Kunka RL; Yin Y; Andrews SM; Callejas S; Ng C
    Eur J Clin Pharmacol; 2004 Jun; 60(4):265-8. PubMed ID: 15114430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of intranasal triamcinolone acetonide and intranasal fluticasone propionate on short-term bone growth and HPA axis in children with allergic rhinitis.
    Skoner DP; Gentile D; Angelini B; Kane R; Birdsall D; Banerji D
    Ann Allergy Asthma Immunol; 2003 Jan; 90(1):56-62. PubMed ID: 12546339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intranasal corticosteroids and adrenal suppression.
    Bruni FM; De Luca G; Venturoli V; Boner AL
    Neuroimmunomodulation; 2009; 16(5):353-62. PubMed ID: 19571596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of repeated once daily dosing of three intranasal corticosteroids on basal and dynamic measures of hypothalamic-pituitary-adrenal-axis activity.
    Wilson AM; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Apr; 101(4 Pt 1):470-4. PubMed ID: 9564799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal loteprednol etabonate in healthy male subjects: pharmacokinetics and effects on endogenous cortisol.
    Hermann R; Locher M; Siebert-Weigel M; LaVallee N; Derendorf H; Hochhaus G
    J Clin Pharmacol; 2004 May; 44(5):510-9. PubMed ID: 15102872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of effect on adult and adolescent hypothalamic-pituitary-adrenal axis function with use of fluticasone furoate nasal spray.
    Patel D; Ratner P; Clements D; Wu W; Faris M; Philpot E
    Ann Allergy Asthma Immunol; 2008 May; 100(5):490-6. PubMed ID: 18517083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPA axis safety of fluticasone furoate nasal spray once daily in children with perennial allergic rhinitis.
    Tripathy I; Levy A; Ratner P; Clements D; Wu W; Philpot E
    Pediatr Allergy Immunol; 2009 May; 20(3):287-94. PubMed ID: 19175889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linagliptin, a dipeptidyl peptidase-4 inhibitor in development for the treatment of type 2 diabetes mellitus: a Phase I, randomized, double-blind, placebo-controlled trial of single and multiple escalating doses in healthy adult male Japanese subjects.
    Sarashina A; Sesoko S; Nakashima M; Hayashi N; Taniguchi A; Horie Y; Graefe-Mody EU; Woerle HJ; Dugi KA
    Clin Ther; 2010 Jun; 32(6):1188-204. PubMed ID: 20637971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent use of intranasal and orally inhaled fluticasone propionate does not affect hypothalamic-pituitary-adrenal-axis function.
    Sheth KK; Cook CK; Philpot EE; Prillaman BA; Witham LA; Faris MA; Klein KC; Rickard KA
    Allergy Asthma Proc; 2004; 25(2):115-20. PubMed ID: 15176496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses.
    Moore KH; Hussey EK; Shaw S; Fuseau E; Duquesnoy C; Pakes GE
    Cephalalgia; 1997 Jun; 17(4):541-50. PubMed ID: 9209776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic-pituitary-adrenal axis function after inhaled corticosteroids: unreliability of urinary free cortisol estimation.
    Fink RS; Pierre LN; Daley-Yates PT; Richards DH; Gibson A; Honour JW
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4541-6. PubMed ID: 12364432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 2-week, crossover study to investigate the effect of fluticasone furoate nasal spray on short-term growth in children with allergic rhinitis.
    Gradman J; Caldwell MF; Wolthers OD
    Clin Ther; 2007 Aug; 29(8):1738-47. PubMed ID: 17919555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety, tolerability, and exposure of ciclesonide nasal spray in healthy and asymptomatic subjects with seasonal allergic rhinitis.
    Nave R; Wingertzahn MA; Brookman S; Kaida S; Matsunaga T
    J Clin Pharmacol; 2006 Apr; 46(4):461-7. PubMed ID: 16554455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple-dose pharmacokinetics and safety of bevirimat, a novel inhibitor of HIV maturation, in healthy volunteers.
    Martin DE; Blum R; Doto J; Galbraith H; Ballow C
    Clin Pharmacokinet; 2007; 46(7):589-98. PubMed ID: 17596104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absolute bioavailability of intranasal fluticasone furoate in healthy subjects.
    Allen A; Down G; Newland A; Reynard K; Rousell V; Salmon E; Scott R
    Clin Ther; 2007 Jul; 29(7):1415-20. PubMed ID: 17825692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Randomized Trial Comparing the Pharmacokinetics, Safety, and Tolerability of DFN-02, an Intranasal Sumatriptan Spray Containing a Permeation Enhancer, With Intranasal and Subcutaneous Sumatriptan in Healthy Adults.
    Munjal S; Gautam A; Offman E; Brand-Schieber E; Allenby K; Fisher DM
    Headache; 2016 Oct; 56(9):1455-1465. PubMed ID: 27613076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of budesonide aqueous nasal spray on hypothalamic-pituitary-adrenal axis function in children with allergic rhinitis.
    Kim KT; Rabinovitch N; Uryniak T; Simpson B; O'Dowd L; Casty F
    Ann Allergy Asthma Immunol; 2004 Jul; 93(1):61-7. PubMed ID: 15281473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis.
    Rosenblut A; Bardin PG; Muller B; Faris MA; Wu WW; Caldwell MF; Fokkens WJ
    Allergy; 2007 Sep; 62(9):1071-7. PubMed ID: 17686110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of GSK961081, a novel inhaled muscarinic antagonist β2 -agonist, and fluticasone propionate administered alone, concurrently and as a combination blend formulation in healthy volunteers.
    Norris V; Ambery C; Riley T
    Clin Pharmacol Drug Dev; 2014 Jul; 3(4):305-13. PubMed ID: 27128837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.